Early Phase Clinical Trials
Helping our clients navigate their Phase I-IB studies
PPD’s early development services keeps an eye toward supporting your later-phase programs.
PPD’s Early Development and Clinical Pharmacology Solutions
Our streamlined services help establish proof-of-concept by reducing time and cost from your development timeline.
Learn more about our Phase I capabilities
EARLY DEVELOPMENT GLOBAL CAPABILITIES
With over 100 studies awarded through our global network in the past five years, our areas of expertise include: renal impairment, hepatic impairment, Japanese Bridging, Chinese Bridging in China and NHV studies.
Early Development Services: ADME Study Capabilities
PPD’s early development services can perform absorption, distribution, metabolism and excretion (ADME) studies to understand how a drug is processed in the human body to assess safety and efficacy.